ArticlePolymers2025
3D Printing of Virucidal Polymer Nanocomposites (PLA/Copper Nanoparticles).
Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Biopolymer-Nanoparticle Interactions in 3D-Printing for Biomedical Applications: Advantages, Limitations and Future Perspectives.Polymers · 2026Review
- A Composite Based onPolymers · 2026Article
- Article
- Development of Filaments for 3D Printing from Poly(Lactic Acid) Polymeric Nanocomposites and Carbon Nanotubes.Polymers · 2025Article
- Review
- Engineering copper and copper-based materials for a post-antibiotic era.Frontiers in bioengineering and biotechnology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metallic nanoparticles with virucidal properties dispersed in a polymeric matrix have gained prominence in the scientific community as a rapid and effective alternative that employs the additive manufacturing (AM) or 3D printing method. This study aims to produce filaments for 3D printing using polymer nanocomposites based on polylactic acid (PLA) and copper nanoparticles (CuNPs) in different proportions. The virucidal activity of various proportions of nanoparticles in PLA was investigated. The composites were produced following a mixture design (DOE) with concentrations ranging from 1% to 2% copper nanoparticles, which were blended with PLA using a single-screw extruder. The samples were characterized by thermogravimetry (TG), differential scanning calorimetry (DSC), tensile strength testing, and fracture analysis using scanning electron microscopy (SEM). A thermal analysis of the composites indicated that the CuNPs contributed to an increase in the degradation temperature and crystallization of the PLA. Sample S7 (1.25% of CuNPs) exhibited a 4% increase in the degradation temperature compared to pure PLA. The best tensile strength results were observed in sample S7 (1.25% of CuNPs), 30% more than sample S3 (1.33% of CuNPs) due to good material cohesion, as evidenced by microscopy analyses. Regarding virucidal analyses, most composites demonstrated virus inhibition activity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.